Literature DB >> 21219446

Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells.

Mauricio J Farfán1, Cecilia S Toro, Eileen M Barry, James P Nataro.   

Abstract

We have previously described a protein termed Shigella enterotoxin 2 (ShET-2), which induces rises in short-circuit current in rabbit ileum mounted in the Ussing chamber. Published reports have postulated that ShET-2 may be secreted by the Shigella type III secretion system (T3SS). In this study, we show that ShET-2 secretion into the extracellular space requires the T3SS in Shigella flexneri 2a strain 2457T and a ShET-2-TEM fusion was translocated into epithelial cells in a T3SS-dependent manner. The ShET-2 gene, sen, is encoded downstream of the ospC1 gene of S. flexneri, and we show that sen is cotranscribed with this T3SS-secreted product. Considering that T3SS effectors have diverse roles in Shigella infection and that vaccine constructs lacking ShET-2 are attenuated in volunteers, we asked whether ShET-2 has a function other than its enterotoxic activity. We constructed a ShET-2 mutant in 2457T and tested its effect on epithelial cell invasion, plaque formation, guinea pig keratoconjunctivitis and interleukin 8 (IL-8) secretion from infected monolayers. Although other phenotypes were not different compared with the wild-type parent, we found that HEp-2 and T84 cells infected with the ShET-2 mutant exhibited significantly reduced IL-8 secretion into the basolateral compartment, suggesting that ShET-2 might participate in the Shigella-induced inflammation of epithelial cells.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219446      PMCID: PMC3055916          DOI: 10.1111/j.1574-695X.2011.00778.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  37 in total

Review 1.  Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.

Authors:  Claude Parsot
Journal:  FEMS Microbiol Lett       Date:  2005-09-15       Impact factor: 2.742

2.  Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli.

Authors:  Susan M Harrington; Maura C Strauman; Cecilia M Abe; James P Nataro
Journal:  Cell Microbiol       Date:  2005-11       Impact factor: 3.715

3.  Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses.

Authors:  Jun Okuda; Takahito Toyotome; Naoyuki Kataoka; Mutsuhito Ohno; Hiroyuki Abe; Yoshiro Shimura; Arefeh Seyedarabi; Richard Pickersgill; Chihiro Sasakawa
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

Review 4.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

5.  Developing live Shigella vaccines using lambda Red recombineering.

Authors:  Ryan T Ranallo; Shoshana Barnoy; Sejal Thakkar; Tonia Urick; Malabi M Venkatesan
Journal:  FEMS Immunol Med Microbiol       Date:  2006-08

6.  Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors.

Authors:  Hiroshi Ashida; Takahito Toyotome; Takeshi Nagai; Chihiro Sasakawa
Journal:  Mol Microbiol       Date:  2007-01-04       Impact factor: 3.501

7.  OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.

Authors:  Daniel V Zurawski; Chieko Mitsuhata; Karen L Mumy; Beth A McCormick; Anthony T Maurelli
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

8.  The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes.

Authors:  Dong Wook Kim; Gerlinde Lenzen; Anne-Laure Page; Pierre Legrain; Philippe J Sansonetti; Claude Parsot
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-14       Impact factor: 11.205

9.  An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses.

Authors:  Laurence Arbibe; Dong Wook Kim; Eric Batsche; Thierry Pedron; Bogdan Mateescu; Christian Muchardt; Claude Parsot; Philippe J Sansonetti
Journal:  Nat Immunol       Date:  2006-12-10       Impact factor: 25.606

10.  A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri.

Authors:  Claude Parsot; Elisabeth Ageron; Christophe Penno; Maria Mavris; Kais Jamoussi; Hélène d'Hauteville; Philippe Sansonetti; Brigitte Demers
Journal:  Mol Microbiol       Date:  2005-06       Impact factor: 3.501

View more
  21 in total

Review 1.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

2.  Applying Fluorescence Resonance Energy Transfer (FRET) to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing.

Authors:  Patrice Newton; Eleanor A Latomanski; Hayley J Newton
Journal:  J Vis Exp       Date:  2016-07-06       Impact factor: 1.355

3.  Shigella: A Highly Virulent and Elusive Pathogen.

Authors:  Mussaret Bano Zaidi; Teresa Estrada-García
Journal:  Curr Trop Med Rep       Date:  2014-06-01

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

5.  Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.

Authors:  Tao Wu; Christen Grassel; Myron M Levine; Eileen M Barry
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.

Authors:  Christina S Faherty; Tao Wu; Carolyn R Morris; Christen L Grassel; David A Rasko; Jill M Harper; Terez Shea-Donohue; Alessio Fasano; Eileen M Barry
Journal:  Gut Microbes       Date:  2016-09-22

8.  Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo.

Authors:  Christina S Faherty; Christina Faherty; Jill M Harper; Terez Shea-Donohue; Eileen M Barry; James B Kaper; Alessio Fasano; James P Nataro
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

9.  Occurrence of genes encoding enterotoxins in uropathogenic Escherichia coli isolates.

Authors:  Mahsa Mirzarazi; Seyedeh Elham Rezatofighi; Mahdi Pourmahdi; Mohamad Reza Mohajeri
Journal:  Braz J Microbiol       Date:  2015-03-01       Impact factor: 2.476

10.  Virulence factors and molecular characteristics of Shigella flexneri isolated from calves with diarrhea.

Authors:  Zhen Zhu; Weiwei Wang; Mingze Cao; Qiqi Zhu; Tenghe Ma; Yongying Zhang; Guanhui Liu; Xuzheng Zhou; Bing Li; Yuxiang Shi; Jiyu Zhang
Journal:  BMC Microbiol       Date:  2021-07-16       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.